1Wanner C, Hori WH. Carnitine abnormalities in patients with renal insufficiency: pathophysiological and therapeutic aspects. Nephron, 1988,50 (20) : 89 - 102.
2Port FK, Hulbert - Shearon TR, Wolfe RA, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis, 1999,33 (3) : 507 -517.
5Thompsin CH, Irish AB, Kemp GJ, et al. The effect of propionyl L - carnitine on skeldtal muscle metabolism in renal failure. Clin Nephrol, 1997,47(6) :372 - 377.
6Hurot JM,Cucherat M, Haugh M, et al. Effects of L- camitine supplementation in maintenance hemodialysis patients. J Am Soc Nephrol,2002,13(3) :708 - 714.
7Cui J, Dasd K, Bertelli A. Effects of L - carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem, 2003,254 ( 1 - 2):227 - 234.
9Ferrari R, Cuuchim F, Visioli O. The metabolical effects of L - carnitine in angina pectoris. Int J Cardiol, 1984,5 (2): 213 - 216.
10Caponnetto S,Canale C,Masperone MA, et al. Efficacy of L - propionyl camitine treatment in patients with left ventrieular dysfunction. Eur Heart J, 1994,15(9) : 1267 - 1273.
4Kata AM. Metabolism of the failing heart [J]. Cardioscience, 1993,4 (4) :199 - 203.
5Saks VA, Strumia E. Phosphocreatine mocular and cellular aspets of the mechanism of cardioprotective actiom [J]. Curr Ther Rer, 1992,53:585 - 598.
6Regitz V, Shug AL, Flock E. Defective myocardial carnitine metabolism in conjestive heart failure secondary to dilated cardiomyopathy and to coronary,hypertensive and valvular heart diseases [J]. Am J Cardiol, 1990,65 (11) :755 - 760,.
7Rizxos I. Three year survival of patients with heart failure causd by dilated cardiomyopathy and L - carnitine administration [J]. Am Heart J, 2000,139(2 pt3) : 120 - 123.
8Calvani M, Reda E, Arrigoni Martelll E, Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normaland pathological conditions[J]. Basic ResCardiol,2000,95(2) :85 - 83.
9Hurot JM,Cucherat M,Haugh M,et al.Effect of levocarnitin supple-mentation in maintenine hemodialysis patients:a systematic review[J].J Am Soc Nephrol,2002,13:709-714.
10Savica V,Calvani M,Benatti P,et al,Carnitine system in uremia patients:molecular and clinical aspects[J].Semin Nephrol,2004,24:464-468.
